{
    "N/R/U": null,
    "Applicant": "Alexion Pharmaceuticals, Inc.",
    "BLA Number": "125513",
    "Proprietary Name": "Strensiq",
    "Proper Name": "asfotase alfa",
    "BLA Type": "351(a)",
    "Strength": "28MG/0.7ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Subcutaneous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "23-Oct-15",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "1743",
    "Product Number": "2",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "23-Oct-22"
}